Cargando…

Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis

The 64K surface protein of budded Autographa californica nuclear polyhedrosis virus (AcMNPV BV) is known to play a role in the functional entry of AcMNPV BV into Spodoptera frugiperda IPLB-SF-21 cells by adsorptive endocytosis. AcV(1), a neutralizing monoclonal antibody, reacts with the 64K protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Volkman, Loy E., Goldsmith, Phyllis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 1988
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172300/
https://www.ncbi.nlm.nih.gov/pubmed/3046120
http://dx.doi.org/10.1016/0042-6822(88)90176-6
_version_ 1783524230982270976
author Volkman, Loy E.
Goldsmith, Phyllis A.
author_facet Volkman, Loy E.
Goldsmith, Phyllis A.
author_sort Volkman, Loy E.
collection PubMed
description The 64K surface protein of budded Autographa californica nuclear polyhedrosis virus (AcMNPV BV) is known to play a role in the functional entry of AcMNPV BV into Spodoptera frugiperda IPLB-SF-21 cells by adsorptive endocytosis. AcV(1), a neutralizing monoclonal antibody, reacts with the 64K protein and in doing so prevents efficient entry. In this communication we report that treatment of AcMNPV BV with either trypsin or proteinase K cleaves the 64K protein into one major fragment of 34.6K and two minor fragments of 36K to 37.2K that are retained with the virus. All of the fragments are glycosylated. Protease treatment does not reduce viral infectivity, but it does result in the destruction of the AcV(1)-reactive epitope; thus AcV(1) is not able to neutralize protease-treated AcMNPV BV. Polyclonal antiserum to BV is able to recognize both cleaved and uncleaved 64K and neutralize both protease-treated and untreated virus. Protease treatment does not diminish the sensitivity of AcMNPV BV to chloroquine, but it does cause the virus to become more susceptible to inactivation by 2-mercaptoethanol (2-ME) even though exposure to 2-ME does not result in dissociation of the fragments from the virus.
format Online
Article
Text
id pubmed-7172300
institution National Center for Biotechnology Information
language English
publishDate 1988
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71723002020-04-22 Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis Volkman, Loy E. Goldsmith, Phyllis A. Virology Article The 64K surface protein of budded Autographa californica nuclear polyhedrosis virus (AcMNPV BV) is known to play a role in the functional entry of AcMNPV BV into Spodoptera frugiperda IPLB-SF-21 cells by adsorptive endocytosis. AcV(1), a neutralizing monoclonal antibody, reacts with the 64K protein and in doing so prevents efficient entry. In this communication we report that treatment of AcMNPV BV with either trypsin or proteinase K cleaves the 64K protein into one major fragment of 34.6K and two minor fragments of 36K to 37.2K that are retained with the virus. All of the fragments are glycosylated. Protease treatment does not reduce viral infectivity, but it does result in the destruction of the AcV(1)-reactive epitope; thus AcV(1) is not able to neutralize protease-treated AcMNPV BV. Polyclonal antiserum to BV is able to recognize both cleaved and uncleaved 64K and neutralize both protease-treated and untreated virus. Protease treatment does not diminish the sensitivity of AcMNPV BV to chloroquine, but it does cause the virus to become more susceptible to inactivation by 2-mercaptoethanol (2-ME) even though exposure to 2-ME does not result in dissociation of the fragments from the virus. Published by Elsevier Inc. 1988-09 2004-02-06 /pmc/articles/PMC7172300/ /pubmed/3046120 http://dx.doi.org/10.1016/0042-6822(88)90176-6 Text en Copyright © 1988 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Volkman, Loy E.
Goldsmith, Phyllis A.
Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis
title Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis
title_full Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis
title_fullStr Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis
title_full_unstemmed Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis
title_short Resistance of the 64k protein of budded Autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis
title_sort resistance of the 64k protein of budded autographa californica nuclear polyhedrosis virus to functional inactivation by proteolysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172300/
https://www.ncbi.nlm.nih.gov/pubmed/3046120
http://dx.doi.org/10.1016/0042-6822(88)90176-6
work_keys_str_mv AT volkmanloye resistanceofthe64kproteinofbuddedautographacalifornicanuclearpolyhedrosisvirustofunctionalinactivationbyproteolysis
AT goldsmithphyllisa resistanceofthe64kproteinofbuddedautographacalifornicanuclearpolyhedrosisvirustofunctionalinactivationbyproteolysis